Toward Standardization in Biotechnology Platforms to Support Smart Manufacturing

The current race to develop and manufacture vaccines and therapeutics to prevent and treat coronavirus disease 2019 (COVID-19) has led to an increased recognition of and investment in various technology platforms, including manufacturing and measurement platforms, across many sectors of biotechnology. We are also witnessing the convergence of multidisciplinary technologies to enable rapid response and capacity building for diagnostics, treatments, and prevention, and in biosurveillance and monitoring. Addressing this global challenge requires smart and distributed manufacturing underpinned by robust standards that are necessary to ensure the quality and consistency of bioproducts.